argenx SE | ARGX - Net Income

Stock Price
717.60
Daily Change
-1.00 -0.14%
Monthly
4.97%
Yearly
11.92%
Q1 Forecast
686.63

argenx SE reported $344.26M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
AstraZeneca USD 2.53B 83M Sep/2025
Galapagos EUR -202.11M 96.36M Sep/2025
Genmab DKK 336M 141M Jun/2025
GlaxoSmithKline GBP 2.01B 570M Sep/2025
GRIFOLS EUR 126.96M 9.9M Sep/2025
Hikma Pharmaceutical USD 119M 14M Jun/2025
Qiagen NV USD 130.04M 33.79M Sep/2025
UCB EUR 857M 649M Dec/2024